4.6 Review

Control the Host Cell Cycle: Viral Regulation of the Anaphase-Promoting Complex

期刊

JOURNAL OF VIROLOGY
卷 87, 期 16, 页码 8818-8825

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.00088-13

关键词

-

类别

资金

  1. Public Health Service grant [R01CA120768]
  2. Burroughs Wellcome Fund

向作者/读者索取更多资源

Viruses commonly manipulate cell cycle progression to create cellular conditions that are most beneficial to their replication. To accomplish this feat, viruses often target critical cell cycle regulators in order to have maximal effect with minimal input. One such master regulator is the large, multisubunit E3 ubiquitin ligase anaphase-promoting complex (APC) that targets effector proteins for ubiquitination and proteasome degradation. The APC is essential for cells to progress through anaphase, exit from mitosis, and prevent a premature entry into S phase. These far-reaching effects of the APC on the cell cycle are through its ability to target a number of substrates, including securin, cyclin A, cyclin B, thymidine kinase, geminin, and many others. Recent studies have identified several proteins from a number of viruses that can modulate APC activity by different mechanisms, highlighting the potential of the APC in driving viral replication or pathogenesis. Most notably, human cytomegalovirus (HCMV) protein pUL21a was recently identified to disable the APC via a novel mechanism by targeting APC subunits for degradation, both during virus infection and in isolation. Importantly, HCMV lacking both viral APC regulators is significantly attenuated, demonstrating the impact of the APC on a virus infection. Work in this field will likely lead to novel insights into viral replication and pathogenesis and APC function and identify novel antiviral and anticancer targets. Here we review viral mechanisms to regulate the APC, speculate on their roles during infection, and identify questions to be addressed in future studies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Virology

The Viral Macrodomain Counters Host Antiviral ADP-Ribosylation

Yousef M. O. Alhammad, Anthony R. Fehr

VIRUSES-BASEL (2020)

Article Biochemistry & Molecular Biology

Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity

Collin D. Heer, Daniel J. Sanderson, Lynden S. Voth, Yousef M. O. Alhammad, Mark S. Schmidt, Samuel A. J. Trammell, Stanley Perlman, Michael S. Cohen, Anthony R. Fehr, Charles Brenner

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Article Virology

Unique Mutations in the Murine Hepatitis Virus Macrodomain Differentially Attenuate Virus Replication, Indicating Multiple Roles for the Macrodomain in Coronavirus Replication

Lynden S. Voth, Joseph J. O'Connor, Catherine M. Kerr, Ethan Doerger, Nancy Schwarting, Parker Sperstad, David K. Johnson, Anthony R. Fehr

Summary: The macrodomain Mac1 within nonstructural protein 3 of coronaviruses has been identified as essential for viral replication, with targeted mutations revealing multiple functions that contribute to the replication of the model CoV MHV. These findings suggest that Mac1 may be a potential target for anti-CoV therapeutics.

JOURNAL OF VIROLOGY (2021)

Article Biochemistry & Molecular Biology

ADP-ribosyltransferases, an update on function and nomenclature

Bernhard Luscher, Ivan Ahel, Matthias Altmeyer, Alan Ashworth, Peter Bai, Paul Chang, Michael Cohen, Daniela Corda, Francoise Dantzer, Matthew D. Daugherty, Ted M. Dawson, Valina L. Dawson, Sebastian Deindl, Anthony R. Fehr, Karla L. H. Feijs, Dmitri V. Filippov, Jean-Philippe Gagne, Giovanna Grimaldi, Sebastian Guettler, Nicolas C. Hoch, Michael O. Hottiger, Patricia Korn, W. Lee Kraus, Andreas Ladurner, Lari Lehtio, Anthony K. L. Leung, Christopher J. Lord, Aswin Mangerich, Ivan Matic, Jason Matthews, George-Lucian Moldovan, Joel Moss, Gioacchino Natoli, Michael L. Nielsen, Mario Niepel, Friedrich Nolte, John Pascal, Bryce M. Paschal, Krzysztof Pawlowski, Guy G. Poirier, Susan Smith, Gyula Timinszky, Zhao-Qi Wang, Jose Yelamos, Xiaochun Yu, Roko Zaja, Mathias Ziegler

Summary: ADP-ribosylation, a post-translational modification of proteins, nucleic acids, and metabolites, plays diverse roles in cellular processes such as stress responses, signaling, and transcriptional regulation. Recent advances in research have identified a wide range of cellular pathways regulated by ADP-ribosylation, highlighting the importance of understanding this mechanism in cell biology.

FEBS JOURNAL (2022)

Article Biochemistry & Molecular Biology

High-Throughput Activity Assay for Screening Inhibitors of the SARS-CoV-2 Mac1 Macrodomain

Morgan Dasovich, Junlin Zhuo, Jack A. Goodman, Ajit Thomas, Robert Lyle McPherson, Aravinth Kumar Jayabalan, Veronica F. Busa, Shang-Jung Cheng, Brennan A. Murphy, Karli R. Redinger, Yousef M. O. Alhammad, Anthony R. Fehr, Takashi Tsukamoto, Barbara S. Slusher, Jurgen Bosch, Huijun Wei, Anthony K. L. Leung

Summary: Viral macrodomains are crucial for virus replication and pathogenesis, making them a promising target for antiviral therapy. Dasatinib has been identified as a potential ADP-ribosylhydrolase inhibitor, showing effectiveness against SARS-CoV-2 and MERS-CoV, but not affecting the closest human homologue MacroD2. This study demonstrates the feasibility of identifying selective inhibitors based on ADP-ribosylhydrolase activity and provides a potential avenue for developing better macrodomain inhibitors as antiviral therapies for SARS-CoV-2 and other viral threats.

ACS CHEMICAL BIOLOGY (2022)

Article Microbiology

The Conserved Macrodomain Is a Potential Therapeutic Target for Coronaviruses and Alphaviruses

Anthony K. L. Leung, Diane E. Griffin, Juergen Bosch, Anthony R. Fehr

Summary: Emerging and re-emerging viral diseases pose continuous threats to public health. Developing a diverse portfolio of antiviral agents is crucial for effective control. The macrodomain, a drug target critical for the replication and pathogenesis of alphaviruses and coronaviruses, has the potential to block virus replication and restore the host's protective interferon response. Macrodomain inhibitors, with their well-defined binding pocket, offer an attractive target for developing direct acting antivirals and complementing current approaches in combating COVID-19 and future viral threats.

PATHOGENS (2022)

Article Multidisciplinary Sciences

MERS-CoV endoribonuclease and accessory proteins jointly evade host innate immunity during infection of lung and nasal epithelial cells

Courtney E. Comar, Clayton J. Otter, Jessica Pfannenstiel, Ethan Doerger, David M. Renner, Li Hui Tan, Stanley Perlman, Noam A. Cohen, Anthony R. Fehr, Susan R. Weiss

Summary: MERS-CoV optimizes its replication by suppressing early innate immune pathways, including interferon production and signaling, through the actions of endoribonuclease (EndoU) and accessory proteins NS4a and NS4b.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Pharmacology & Pharmacy

Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening

Anu Roy, Yousef M. Alhammad, Peter McDonald, David K. Johnson, Junlin Zhuo, Sarah Wazir, Dana Ferraris, Lari Lehtio, Anthony K. L. Leung, Anthony R. Fehr

Summary: This study focuses on screening for potential inhibitors of the SARS-CoV-2 conserved macrodomain (Mac1). Five compounds from three chemotypes were identified, which show inhibitory effects on Mac1-ADP-ribose binding, ADP-ribosylhydrolase activity, and direct Mac1 binding, making them strong candidates for the development of highly effective Mac1 inhibitors.

ANTIVIRAL RESEARCH (2022)

Article Biochemistry & Molecular Biology

Design, synthesis and evaluation of inhibitors of the SARS-CoV-2 nsp3 macrodomain

Lavinia M. Sherrill, Elva E. Joya, AnnMarie Walker, Anuradha Roy, Yousef M. Alhammad, Moriama Atobatele, Sarah Wazir, George Abbas, Patrick Keane, Junlin Zhuo, Anthony K. L. Leung, David K. Johnson, Lari Lehtio, Anthony R. Fehr, Dana Ferraris

Summary: A series of amino acid based compounds were designed and synthesized to investigate their inhibitory activity against the SARS-CoV-2 nsp3 macrodomain. Compound 15c was identified as a low-micromolar inhibitor and demonstrated selectivity for coronavirus macrodomains.

BIOORGANIC & MEDICINAL CHEMISTRY (2022)

Article Microbiology

PARP14: A key ADP-ribosylating protein in host-virus interactions?

Srivatsan Parthasarathy, Anthony R. Fehr

Summary: The translation discusses the impact of posttranslational modifications (PTMs) on protein functions, focusing on the role of ADP-ribosylation. Specifically, it highlights the importance of PARP14, a MARylating enzyme, in anti-inflammatory and antiviral responses, while also emphasizing the need for further studies to elucidate its specific roles and mechanisms during viral infections.

PLOS PATHOGENS (2022)

Article Microbiology

Inhibitors of One or More Cellular Aurora Kinases Impair the Replication of Herpes Simplex Virus 1 and Other DNA and RNA Viruses with Diverse Genomes and Life Cycles

Cindy Y. Ly, Jessica Pfannenstiel, Anil Pant, Zhilong Yang, Anthony R. Fehr, Maxim S. Rodzkin, David J. Davido

Summary: In this study, aurora kinase inhibitors were found to significantly reduce gene expression and viral replication of herpes simplex virus 1 (HSV-1). Furthermore, these inhibitors also showed inhibitory effects on the replication of other RNA and DNA viruses. These findings suggest a novel role for aurora kinases in the replication of diverse viruses.

MICROBIOLOGY SPECTRUM (2023)

Article Virology

PARP12 is required to repress the replication of a Mac1 mutant coronavirus in a cell- and tissue-specific manner

Catherine M. Kerr, Srivatsan Parthasarathy, Nancy Schwarting, Joseph J. O'Connor, Jessica J. Pfannenstiel, Emily Giri, Sunil More, Robin C. Orozco, Anthony R. Fehr

Summary: PARP12 is an important mediator of the antiviral response to coronaviruses, but additional PARPs or innate immune factors contribute to virus attenuation in mice. PARP12 knockout increases Mac1 mutant virus replication and liver pathology in mice.

JOURNAL OF VIROLOGY (2023)

Article Microbiology

Two Commercially Available Blood-Stabilization Reagents Serve as Potent Inactivators of Coronaviruses

Joseph J. O'Connor, Lynden Voth, Jeremiah Athmer, Nicholas M. George, Christopher M. Connelly, Anthony R. Fehr

Summary: Testing two commercially available blood collection tube blood-stabilization reagents, cfDNA and CytoChex, it was found that they can rapidly inactivate coronaviruses and effectively preserve viral RNA stability for a certain period of time.

PATHOGENS (2023)

Review Microbiology

An Update on the Current State of SARS-CoV-2 Mac1 Inhibitors

Joseph J. O'Connor, Dana Ferraris, Anthony R. Fehr

Summary: This article summarizes the progress in the search for inhibitors of the SARS-CoV-2 Mac1 protein. Various unique chemical inhibitors have been successfully created using high-throughput screening and chemical modifications.

PATHOGENS (2023)

Article Virology

The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase

Yousef M. O. Alhammad, Maithri M. Kashipathy, Anuradha Roy, Jean-Philippe Gagne, Peter McDonald, Philip Gao, Louis Nonfoux, Kevin P. Battaile, David K. Johnson, Erik D. Holmstrom, Guy G. Poirier, Scott Lovell, Anthony R. Fehr

Summary: The Mac1 proteins in SARS-CoV-2 and other CoVs are MAR-hydrolases with similar functions, suggesting compounds targeting these proteins may have broad anti-CoV activity. Understanding the biochemistry and enzyme activity of these proteins is critical for developing novel therapeutic strategies against COVID-19.

JOURNAL OF VIROLOGY (2021)

暂无数据